The safety and efficacy of vortioxetine for acute treatment of major depressive disorder: a systematic review and meta-analysis

BACKGROUND: Vortioxetine is the first mixed serotonin agonist and antagonist antidepressant approved in the US. We sought to evaluate all published and unpublished data available to determine the efficacy and harms of vortioxetine in adults with major depressive disorder. METHODS: We used a predefin...

Volledige beschrijving

Bewaard in:
Bibliografische gegevens
Gepubliceerd in:Syst Rev
Hoofdauteurs: Meeker, Amanda S, Herink, Megan C, Haxby, Dean G, Hartung, Daniel M
Formaat: Artigo
Taal:Inglês
Gepubliceerd in: BioMed Central 2015
Onderwerpen:
Research
Online toegang:https://ncbi.nlm.nih.gov/pmc/articles/PMC4351824/
https://ncbi.nlm.nih.gov/pubmed/25874839
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13643-015-0001-y
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!

Gelijkaardige items